HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
* Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility inGuangzhou (CN) * HaemaLogiX will leverage Lonza's regulatory expertise, global manufacturing footprint, and extensive experience in ...
2022-01-28 05:30
5776
Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide
BASEL, Switzerland and BRAINE-L'ALLEUD, Belgium and MALMO, Sweden, Dec. 7, 2016 /PRNewswire/ -- Lonza and the PolyPeptide Group jointly announced today that PolyPeptide Laboratories Holding (PPL) AB has entered into a definitive agreement with Lonza Sales AG and Lonza AG (both 100% affiliates of ...
2016-12-07 22:58
2090
